Survival and quality of life for patients on hemodialysis therapy remain poor despite substantial research efforts. Existing trials often report surrogate outcomes that may not be relevant to patients and clinicians. The aim of this project was to generate a consensus-based prioritized list of core outcomes for trials in hemodialysis
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
Abstract Background Chronic kidney disease is a signi...
Evidence-informed decision making in clinical care and policy in nephrology is undermined by trials ...
Evidence-informed decision making in clinical care and policy in nephrology is undermined by trials ...
BACKGROUND: Chronic kidney disease is a significant contributor to mortality and morbidity worldwide...
Background: Chronic kidney disease is a significant contributor to mortality and morbidity worldwide...
International audienceBACKGROUND: Worldwide, approximately 11% of patients on dialysis receive perit...
Vascular access outcomes in hemodialysis are critically important for patients and clinicians, but f...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
Vascular access outcomes in hemodialysis are critically important for patients and clinicians, but f...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
Abstract Background Chronic kidney disease is a signi...
Evidence-informed decision making in clinical care and policy in nephrology is undermined by trials ...
Evidence-informed decision making in clinical care and policy in nephrology is undermined by trials ...
BACKGROUND: Chronic kidney disease is a significant contributor to mortality and morbidity worldwide...
Background: Chronic kidney disease is a significant contributor to mortality and morbidity worldwide...
International audienceBACKGROUND: Worldwide, approximately 11% of patients on dialysis receive perit...
Vascular access outcomes in hemodialysis are critically important for patients and clinicians, but f...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
Vascular access outcomes in hemodialysis are critically important for patients and clinicians, but f...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...